Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide
Open Access
- 8 December 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (12), 4072-4073
- https://doi.org/10.1002/art.20617
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathyArthritis & Rheumatism, 2003
- Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open‐label studyRheumatology, 2002
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisThe New England Journal of Medicine, 2000
- Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trialsArthritis & Rheumatism, 2000
- Development of lupus‐related side‐effects in patients with early RA during sulphasalazine treatment—the role of IL‐10 and HLARheumatology, 2000
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1998
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995